In participants with AMD or a high PRS, we observed marked dysregulation of CFHR4 and CFHR5, reinforcing the hypothesis that activation of the alternative complement pathway, mediated by dysregulation of the CFHR protein family35, plays a crucial role in the pathogenesis of AMD. This evidence concerns the gene CFHR5 and age-related macular degeneration.